Michael Hassett, MD, MPH, discusses the rise of oral therapeutics in breast cancer care, emphasizing patient support, education, and overcoming financial barriers for better outcomes.
Media ReleaseCOPENHAGEN, Denmark; More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile ...
Raipur oncologist Dr. Jayesh Sharma stresses that early cancer signs are often subtle and easily overlooked. Persistent, ...